Theranostic MUC-1 aptamer targeted gold coated superparamagnetic iron oxide nanoparticles for magnetic resonance imaging and photothermal therapy of colon cancer
Source abstract
Abstract
Favorable physiochemical properties and the capability to accommodate targeting moieties make superparamegnetic iron oxide nanoparticles (SPIONs) popular theranostic agents. In this study, we engineered SPIONs for magnetic resonance imaging (MRI) and photothermal therapy of colon cancer cells. SPIONs were synthesized by microemulsion method and were then coated with gold to reduce their cytotoxicity and to confer photothermal capabilities. Subsequently, the NPs were conjugated with thiol modified MUC-1 aptamers. The resulting NPs were spherical, monodisperse and about 19nm in size, as shown by differential light scattering (DLS) and transmission electron microscopy (TEM). UV and X-ray photoelectron spectroscopy (XPS) confirmed the successful gold coating. MTT results showed that Au@SPIONs have insignificant cytotoxicity at the concentration range of 10-100μg/ml (P>0.05) and that NPs covered with protein corona exerted lower cytotoxicity than bare NPs. Furthermore, confocal microscopy confirmed the higher uptake of aptamer-Au@SPIONs in comparison with non-targeted SPIONs. MR imaging revealed that SPIONs produced significant contrast enhancement in vitro and they could be exploited as contrast agents. Finally, cells treated with aptamer-Au@SPIONs exhibited a higher death rate compared to control cells upon exposure to near infrared light (NIR). In conclusion, MUC1-aptamer targeted Au@SPIONs could serve as promising theranostic agents for simultaneous MR imaging and photothermal therapy of cancer cells.
Source: europepmc · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Nanoparticle-Based Drug Delivery · Advanced biosensing and bioanalysis techniques · Graphene and Nanomaterials Applications
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (46)
Show source-provided references
1. Cancer statistics 2015, CA10.3322/caac.21254 ↗
2. Superparamagnetic iron oxide nanoparticles for delivery of therapeutic agents: opportunities and challenges10.1517/17425247.2014.924501 ↗
3. Superparamagnetic iron oxide nanoparticles for in vivo molecular and cellular imaging10.1002/cmmi.1638 ↗
4. Will immunogenicity limit the use, efficacy, and future development of therapeutic monoclonal antibodies?10.1128/CDLI.1.4.365-372.1994 ↗
5. Clinical issues in antibody design10.1016/S0167-7799(00)88968-4 ↗
6. Antibody-magnetite nanoparticles: in vitro characterization of a potential tumor-specific contrast agent for magnetic resonance imaging10.1021/bc00023a007 ↗
7. Nanoparticle and targeted systems for cancer therapy10.1016/j.addr.2012.09.033 ↗
8. Nanoparticles functionalised with recombinant single chain Fv antibody fragments (scFv) for the magnetic resonance imaging of cancer cells10.1016/j.biomaterials.2009.10.036 ↗
9. Targeted drug delivery via the folate receptor10.1016/S0169-409X(99)00062-9 ↗
10. Recognition of subtype non-small cell lung cancer by DNA aptamers selected from living cells10.1039/b904476k ↗
11. Cancer cell targeting using multiple aptamers conjugated on nanorods10.1021/ac702322j ↗
12. Gold-coated iron nanoparticles for biomedical applications10.1063/1.1555312 ↗
13. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods10.1021/ja057254a ↗
14. Multimodal gadolinium‐enriched DNA–gold nanoparticle conjugates for cellular imaging10.1002/anie.200904666 ↗
15. Synthesis and in vitro evaluation of bone-seeking superparamagnetic iron oxide nanoparticles as contrast agents for imaging bone metabolic activity10.1021/am4010495 ↗
16. Synthesis of Fe oxide core/Au shell nanoparticles by iterative hydroxylamine seeding10.1021/nl035253f ↗
17. Nanotoxicology: advances and pitfalls in research methodology10.2217/nnm.15.130 ↗
18. Physical–chemical aspects of protein corona: relevance to in vitro and in vivo biological impacts of nanoparticles10.1021/ja107583h ↗
19. Temperature: the ignored factor at the nanobio interface10.1021/nn305337c ↗
20. Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging10.1161/01.CIR.0000068315.98705.CC ↗
21. Magnetodendrimers allow endosomal magnetic labeling and in vivo tracking of stem cells10.1038/nbt1201-1141 ↗
22. Magnetic fluid hyperthermia (MFH): cancer treatment with AC magnetic field induced excitation of biocompatible superparamagnetic nanoparticles10.1016/S0304-8853(99)00088-8 ↗
23. Nanoimmunoliposome delivery of superparamagnetic iron oxide markedly enhances targeting and uptake in human cancer cells in vitro and in vivo, Nanomedicine: nanotechnology
24. Fe3O4 nanoparticles engineered for plasmid DNA delivery to Escherichia coli10.1007/s11051-014-2521-0 ↗
25. Fluorescent and superparamagnetic hybrid quantum clusters for magnetic separation and imaging of cancer cells from blood10.1039/c1nr10900f ↗
26. Superparamagnetic iron oxide nanoparticle probes for molecular imaging10.1007/s10439-005-9002-7 ↗
27. Silica-and alkoxysilane-coated ultrasmall superparamagnetic iron oxide particles: a promising tool to label cells for magnetic resonance imaging10.1021/la061879k ↗
28. Synthesis, magnetic characterization, and sensing applications of novel dextran-coated iron oxide nanorods10.1021/cm8031863 ↗
29. Arami · 2011 · 163
30. Effective PEGylation of iron oxide nanoparticles for high performance in vivo cancer imaging10.1002/adfm.201001658 ↗
31. Enhanced stability of polyacrylate-coated magnetite nanoparticles in biorelevant media10.1016/j.colsurfb.2012.01.042 ↗
32. Magnetic nanoparticles for theragnostics10.1016/j.addr.2009.03.007 ↗
33. Magnetic nanoparticles in MR imaging and drug delivery10.1016/j.addr.2008.03.018 ↗
34. Saie · 2015 · 245
35. What the cell sees in bionanoscience10.1021/ja910675v ↗
36. Nanoparticle size matters in the formation of plasma protein coronas on Fe3O4 nanoparticles10.1016/j.colsurfb.2014.06.016 ↗
37. Protein corona-mediated mitigation of cytotoxicity of graphene oxide10.1021/nn200021j ↗
38. Effects of the presence or absence of a protein corona on silica nanoparticle uptake and impact on cells10.1021/nn300223w ↗
39. Protein-nanoparticle interactions: what does the cell see?10.1038/nnano.2009.248 ↗
40. Multifunctional inorganic nanoparticles for imaging, targeting, and drug delivery10.1021/nn800072t ↗
41. The sensitivity to hyperthermia of human granulocyte/macrophage progenitor cells (CFU-GM) derived from blood or marrow of normal subjects and patients with chronic granulocytic leukaemia10.1038/bjc.1984.251 ↗
42. Magnetic nanoparticles: synthesis, protection, functionalization, and application10.1002/anie.200602866 ↗
43. Gold nanorods mediate tumor cell death by compromising membrane integrity10.1002/adma.200701974 ↗
44. Selective photothermal efficiency of citrate capped gold nanoparticles for destruction of cancer cells10.1016/j.yexcr.2011.04.010 ↗
45. In vitro comparison of the photothermal anticancer activity of graphene nanoparticles and carbon nanotubes10.1016/j.biomaterials.2010.10.030 ↗
46. In vitro photothermal study of gold nanoshells functionalized with small targeting peptides to liver cancer cells